Chemcrux Enterprises Limited (BOM:540395)

Market Cap	1.16B -29.0%
Revenue (ttm)	860.81M +24.0%
Net Income	41.43M +49.7%
EPS	2.83 +53.2%
Shares Out	14.81M
PE Ratio	27.59
Forward PE	n/a
Dividend	1.00 (1.28%)
Ex-Dividend Date	Sep 10, 2026

Volume	837
Open	77.00
Previous Close	80.76
Day's Range	74.00 - 79.00
52-Week Range	64.00 - 158.60
Beta	0.47
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2026

About Chemcrux Enterprises

Chemcrux Enterprises Limited engages in the manufacture and sale of intermediates and chemicals in India. Its chemicals and intermediates products are used in the manufacture of bulk drugs active pharmaceutical ingredients, electro-plating, pharmaceuticals, dyes, and pigments. The company offers chloro benzoic, nitro benzoic acid, nitro salicylic, dichloro benzoic acid, chloro nitro benzoic acid, lasamide, arabonic acid sodium salt, chloro benzoic acid sulfonamide, BPEA sulfonamide, para and ortho chloro benzoyl chloride, and chloro benzoyl chl...

• Industry: Chemicals and Allied Products
• Founded: 1983
• Employees: 99
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540395

Financial Performance

In fiscal year 2026, Chemcrux Enterprises's revenue was 806.46 million, an increase of 15.19% compared to the previous year's 700.10 million. Earnings were 37.31 million, a decrease of -4.66%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 23, 2026

Data Sources Report a data error